Internet Gaming Disorder and Social Media Addiction: Diagnostic Criteria, Neuroscience, and Evidence-Based Treatment

The rapid proliferation of digital technologies — particularly online gaming platforms and social media networks — has introduced a class of behavioral problems that increasingly mirror the phenomenology of substance use disorders. Internet Gaming Disorder (IGD) and Problematic Social Media Use (PSMU), sometimes colloquially termed "social media addiction," represent the two most clinically significant manifestations of technology-related compulsive behavior. Both involve loss of control over use, functional impairment, and continuation despite negative consequences — the hallmark triad of addictive disorders.

The nosological status of these conditions remains a subject of active debate. IGD was included in Section III of the DSM-5 (2013) as a "Condition for Further Study," and was later carried forward in the DSM-5-TR (2022) under the same provisional status. In contrast, the World Health Organization took a more decisive step: Gaming Disorder was formally included in the ICD-11 (2019) under "Disorders due to addictive behaviours" (code 6C51), alongside Gambling Disorder. Problematic social media use has not yet received formal diagnostic recognition in either system, though it is the subject of rapidly accumulating research and growing clinical demand.

This article provides a detailed clinical review of both conditions, covering diagnostic criteria and their controversies, neurobiological substrates, epidemiology, comorbidity patterns, treatment approaches with available outcome data, and prognostic factors. The evidence base, while younger than that for substance use disorders or gambling disorder, has matured considerably over the past decade and supports the conceptualization of these phenomena as genuine clinical entities warranting systematic intervention.

Internet Gaming Disorder (DSM-5-TR Section III)

The DSM-5-TR proposes nine criteria for Internet Gaming Disorder, modeled loosely on the criteria for Gambling Disorder and Substance Use Disorders. A provisional diagnosis requires endorsement of five or more of the following over a 12-month period:

• Preoccupation with internet games (gaming becomes the dominant activity in daily life)
• Withdrawal symptoms when gaming is taken away (typically irritability, anxiety, or sadness — not physiological withdrawal)
• Tolerance — the need to spend increasing amounts of time gaming to achieve satisfaction
• Unsuccessful attempts to control participation in internet games
• Loss of interest in previous hobbies and entertainment as a result of gaming
• Continued excessive use despite knowledge of psychosocial problems
• Deception of family members, therapists, or others regarding the amount of gaming
• Use of internet games to escape or relieve negative mood states (e.g., helplessness, guilt, anxiety)
• Jeopardizing or losing a significant relationship, job, or educational or career opportunity because of gaming

The DSM-5-TR notes that the condition does not include internet gambling, use of the internet for required business or professional activities, other recreational or social internet use, or use of sexual internet sites. The threshold of five out of nine criteria has been debated; some researchers have argued it may be too liberal, while others suggest the criteria may conflate engagement with pathology — particularly the "preoccupation" and "escape" criteria, which are common among non-pathological gamers.

Gaming Disorder (ICD-11 — 6C51)

The ICD-11 adopted a more parsimonious approach, defining Gaming Disorder by three core features:

• Impaired control over gaming (onset, frequency, intensity, duration, termination, context)
• Increasing priority given to gaming to the extent that it takes precedence over other life interests and daily activities
• Continuation or escalation of gaming despite the occurrence of negative consequences

The behavior pattern must be of sufficient severity to result in significant impairment in personal, family, social, educational, occupational, or other important areas of functioning, and must normally be evident for at least 12 months, although this period may be shortened if all criteria are met and symptoms are severe. The ICD-11 approach prioritizes functional impairment over symptom counting and is generally regarded as more conservative.

Problematic Social Media Use: A Diagnostic Vacuum

No formal diagnostic criteria exist for PSMU in either the DSM-5-TR or ICD-11. However, a robust body of research has used adapted criteria from IGD or Gambling Disorder. The most widely used screening instrument is the Bergen Social Media Addiction Scale (BSMAS), developed by Andreassen and colleagues (2016), which applies six core addiction components (salience, mood modification, tolerance, withdrawal, conflict, and relapse) specifically to social media use. Each item is rated on a 5-point Likert scale; a score of 19 or above on the 6-item version has been proposed as a clinical cutoff, though sensitivity and specificity data vary across populations.

Other validated instruments include the Social Media Disorder Scale (SMD-Scale) by van den Eijnden et al. (2016), which directly mirrors the nine DSM-5 IGD criteria adapted for social media, using a dichotomous (yes/no) format with a threshold of five or more endorsed items. The lack of consensus on which instrument best identifies clinically meaningful cases remains a significant limitation.

Differential Diagnosis Pitfalls

Clinicians should be aware of several differential diagnostic challenges:

• High engagement vs. disorder: Many individuals spend extensive time gaming or on social media without functional impairment. The critical discriminator is not hours spent but rather loss of control and impairment. Studies by Charlton and Danforth (2007) demonstrated that core addiction criteria (e.g., conflict, withdrawal, relapse) discriminate between pathological and high-engagement users better than peripheral criteria (tolerance, mood modification).
• Primary mood/anxiety disorders: Excessive gaming or social media use frequently occurs as a symptom of underlying depression or social anxiety disorder rather than as an independent behavioral addiction. When the excessive use remits with treatment of the primary mood or anxiety disorder, IGD or PSMU should not be diagnosed independently.
• ADHD: Attention-deficit/hyperactivity disorder shows strong comorbidity with IGD (discussed below) and shares features such as impulsivity and difficulty disengaging. The temporal relationship and treatment response should guide differential diagnosis.
• Autism spectrum disorder: Intense, circumscribed interests — including gaming — are a core feature of ASD and should not be conflated with addictive gaming unless the additional criteria (loss of control, impairment, continuation despite harm) are clearly met.

Internet Gaming Disorder

Prevalence estimates for IGD vary widely depending on the population studied, the instrument used, and the diagnostic threshold applied. A large-scale meta-analysis by Stevens et al. (2021), encompassing 53 studies and over 226,000 participants across multiple countries, estimated the pooled global prevalence of IGD at 3.05% (95% CI: 2.38–3.91%). Prevalence was highest in Asian samples (particularly South Korea, China, and Japan) at approximately 4.0–5.9%, followed by European and North American samples at approximately 1.0–3.5%. These differences may reflect genuine variation in gaming culture and infrastructure, but also measurement heterogeneity.

Demographically, IGD shows a strong male predominance, with male-to-female ratios ranging from 2:1 to 3:1 across studies. The peak age of onset is in adolescence and young adulthood (ages 12–25), though the condition can present at any age. The WHO's Global Burden of Disease study has not yet provided disability-adjusted life year (DALY) estimates for gaming disorder, but several national health systems (notably South Korea's) have begun tracking it as a public health indicator.

Problematic Social Media Use

Estimates for PSMU are even more variable. A systematic review and meta-analysis by Cheng et al. (2021) reported a pooled prevalence of approximately 5% globally, though estimates ranged from 1.7% to as high as 33% depending on criteria and methodology. Using stricter criteria (e.g., the BSMAS cutoff of ≥19), prevalence in community samples of young adults is typically 3–8%.

Unlike IGD, PSMU shows a more balanced or even female-predominant gender distribution, reflecting the gendered patterns of social media platform use. Adolescent girls and young women show particularly high rates of PSMU, which intersects with elevated rates of depression, body dissatisfaction, and social comparison in these groups. The Surgeon General's Advisory on Social Media and Youth Mental Health (2023) highlighted that up to 95% of U.S. adolescents aged 13–17 use social media platforms, with more than one-third reporting use as "almost constant."

A critical methodological concern across this literature is the gap between screening-identified "cases" and clinically confirmed diagnoses. Most prevalence studies rely on self-report screening instruments rather than structured clinical interviews, which likely inflates estimates.

Mesolimbic Dopamine System and Reward Processing

The neurobiological model of behavioral addictions, including IGD and PSMU, centers on dysregulation of the mesolimbic dopaminergic pathway — the ventral tegmental area (VTA) to nucleus accumbens (NAc) circuit that mediates reward anticipation, reinforcement learning, and motivated behavior. Functional neuroimaging studies using fMRI have consistently demonstrated that exposure to gaming cues in individuals with IGD elicits enhanced activation of the ventral striatum and prefrontal cortex, paralleling the cue-reactivity patterns observed in substance use disorders and gambling disorder.

A landmark study by Koepp et al. (1998) first demonstrated that video game play increases striatal dopamine release, with PET imaging showing approximately a doubling of dopamine levels in the ventral striatum during gaming — comparable in magnitude to the dopamine release observed with low-dose amphetamine. Subsequent PET studies in individuals with established IGD have shown reduced D2/D3 receptor availability in the striatum, suggesting downregulation of dopamine receptors — a neuroadaptation consistent with the tolerance phenomenon described clinically.

Ko et al. (2009) conducted one of the earliest controlled fMRI studies of cue-induced craving in IGD. They found that individuals with IGD showed significantly greater activation in the right orbitofrontal cortex, right nucleus accumbens, bilateral anterior cingulate, medial frontal cortex, and right dorsolateral prefrontal cortex when exposed to gaming images compared to neutral images — an activation pattern that correlated with self-reported gaming urge and closely resembled patterns seen in substance cue-reactivity paradigms.

Prefrontal Cortex and Impaired Inhibitory Control

Beyond reward hypersensitivity, IGD and PSMU are associated with deficits in top-down cognitive control mediated by the prefrontal cortex. A meta-analysis of neuroimaging studies by Yao et al. (2017) found consistent hypoactivation of the dorsolateral prefrontal cortex (dlPFC) and anterior cingulate cortex (ACC) during tasks requiring response inhibition (e.g., Go/No-Go, Stroop tasks) in IGD subjects. This prefrontal hypofunction mirrors findings in substance use disorders and is thought to underlie the impaired control over use that is clinically central to these conditions.

Structural MRI studies have identified reduced gray matter volume in the prefrontal cortex, orbitofrontal cortex, and insula in individuals with IGD, as well as reduced white matter integrity (lower fractional anisotropy on diffusion tensor imaging) in tracts connecting frontal control regions to subcortical reward structures. Yuan et al. (2011) reported reduced gray matter density in the bilateral dlPFC, supplementary motor area, orbitofrontal cortex, cerebellum, and left rostral ACC in adolescents with internet addiction, with the degree of reduction correlating with duration of the condition.

Serotonin, Norepinephrine, and Glutamate

While dopamine has received the most attention, other neurotransmitter systems are implicated. Serotonergic dysfunction — specifically reduced 5-HT transporter availability measured via SPECT — has been reported in individuals with internet addiction, paralleling findings in impulsive-compulsive spectrum disorders. This provides a rationale for the use of SSRIs in treatment, though the evidence remains limited.

The glutamatergic system is of increasing interest. Proton magnetic resonance spectroscopy (¹H-MRS) studies have found altered glutamate-to-creatine ratios in the ACC of individuals with IGD, suggesting disrupted excitatory neurotransmission in cognitive control circuits. This finding has prompted exploration of glutamate-modulating agents (e.g., N-acetylcysteine) as potential treatments, drawing parallels with their use in gambling disorder and substance use disorders.

Noradrenergic dysregulation is implicated primarily through the high comorbidity of IGD with ADHD. Medications that enhance noradrenergic and dopaminergic tone (e.g., bupropion, methylphenidate) have shown preliminary efficacy in open-label trials, though the mechanism may be partly through treatment of comorbid ADHD symptoms.

Genetic and Epigenetic Factors

Twin studies have estimated the heritability of problematic internet use at approximately 48–58% (Li et al., 2014). Candidate gene studies have implicated several polymorphisms linked to dopaminergic function:

• DRD2 Taq1A polymorphism (the A1 allele, associated with reduced D2 receptor density): found at higher frequency in individuals with internet addiction in South Korean samples
• COMT Val158Met polymorphism: the Val/Val genotype, associated with lower prefrontal dopamine availability and poorer executive function, has been associated with higher IGD risk in some studies
• 5-HTTLPR short allele: associated with serotonin transporter efficiency and linked to internet addiction risk, particularly in the context of adverse childhood experiences

These findings are preliminary, based on small candidate-gene studies, and have not been consistently replicated in genome-wide association studies (GWAS). The genetics of IGD and PSMU remain in an early stage, and polygenic risk scores have not yet been developed with sufficient predictive power for clinical application.

Social Reward Processing in PSMU

Neuroimaging research on PSMU specifically has highlighted dysregulation in social reward processing circuits. Receiving "likes" or positive social feedback on social media platforms activates the ventral striatum and ventromedial prefrontal cortex — regions central to social reward valuation. Sherman et al. (2016) demonstrated using fMRI in adolescents that viewing Instagram photos with many likes (vs. few likes) produced greater activation in the nucleus accumbens, ventral tegmental area, and social cognition regions (including the temporoparietal junction and precuneus). This social reward sensitivity may create a particularly potent reinforcement loop: post → social feedback → dopaminergic reward → increased posting — a mechanism that platform algorithms are engineered to exploit through variable-ratio reinforcement schedules.

Both IGD and PSMU show high rates of psychiatric comorbidity, which complicates diagnosis, treatment planning, and prognosis. The comorbidity literature is dominated by cross-sectional studies, making causal inferences difficult, but certain patterns are robust:

Depression and Anxiety

Major Depressive Disorder (MDD) is the most frequently comorbid condition with both IGD and PSMU. Meta-analytic data indicate that individuals with IGD are approximately 2.5–3.5 times more likely to meet criteria for MDD compared to non-gaming or non-problematic gaming controls. A meta-analysis by González-Bueso et al. (2018) reported that comorbid depression was present in approximately 40–60% of IGD samples. The relationship is likely bidirectional: depression increases vulnerability to escapist gaming, while excessive gaming (with its associated social withdrawal, sleep disruption, and functional impairment) exacerbates depressive symptoms.

For PSMU, the association with depression and anxiety may be even stronger, particularly in adolescent girls. Longitudinal data from the UK Millennium Cohort Study found that social media use of 3+ hours per day at age 14 was associated with increased risk of clinically significant depressive symptoms at age 17, with stronger effects in females (OR ≈ 2.1 for girls vs. 1.3 for boys). Social comparison, cyberbullying exposure, and disrupted sleep mediate this relationship.

Social Anxiety Disorder (SAD) is particularly prevalent among individuals with PSMU (estimated comorbidity: 25–40%). Some individuals use social media as a lower-threat alternative to face-to-face social interaction, creating a pattern of avoidance that maintains and potentially worsens social anxiety — the "social compensation" hypothesis.

ADHD

The comorbidity between IGD and ADHD is well-documented, with estimates of co-occurring ADHD in IGD samples ranging from 20–45%. The impulsivity dimension of ADHD is thought to be the primary shared vulnerability. A meta-analysis by Wang et al. (2017) found a moderate-to-large association between ADHD symptoms and internet gaming problems (pooled r = 0.31). Clinically, untreated ADHD is a significant barrier to behavioral interventions for IGD, as the executive function deficits compromise self-monitoring and behavioral scheduling strategies.

Substance Use Disorders

Co-occurring substance use, particularly alcohol and cannabis, is reported in approximately 10–25% of IGD samples, though rates vary significantly by population (higher in clinical and treatment-seeking samples). The shared neurobiological substrate — mesolimbic dopamine dysregulation — likely accounts for this overlap, and co-occurring substance use predicts poorer treatment outcomes.

Sleep Disorders

Gaming and social media use are strongly associated with disrupted sleep architecture, delayed sleep-wake phase, and insomnia. Estimates suggest that 50–75% of individuals meeting criteria for IGD or severe PSMU report clinically significant sleep disturbance. The mechanisms include direct displacement of sleep time, blue light exposure suppressing melatonin secretion, and arousal from gaming or social media content interfering with sleep onset. Sleep disruption, in turn, worsens mood, executive function, and impulse control — creating a vicious cycle that maintains the behavioral addiction.

Suicidality

Emerging data link severe IGD and PSMU with elevated suicidal ideation and self-harm, though the evidence is primarily cross-sectional. A study by Kim et al. (2016) in a large South Korean adolescent sample found that IGD was associated with a 2.3-fold increased risk of suicidal ideation after controlling for depression and other psychiatric comorbidity. Whether this risk is directly attributable to gaming disorder or mediated entirely through comorbid depression remains unclear, but the association warrants routine suicidality screening in this population.

Cognitive-Behavioral Therapy (CBT)

CBT is the best-studied and most widely recommended psychotherapeutic approach for IGD. Adapted CBT protocols for IGD (often termed CBT-IA, after Young's model for internet addiction) typically involve 8–15 sessions and include psychoeducation about addiction mechanisms, cognitive restructuring of gaming-related beliefs (e.g., "I can't cope without gaming," "My online identity is my real self"), behavioral scheduling and activity replacement, identification and management of triggers, and relapse prevention planning.

A meta-analysis by Winkler et al. (2013) examined psychological and pharmacological interventions for internet addiction broadly (including IGD) and found that CBT produced a large overall effect size (d = 1.12) on internet addiction severity scores. However, the authors noted that most included studies lacked active control groups and had significant risk of bias.

More recent controlled trials have confirmed CBT's efficacy. Young (2013) reported in a controlled study that 12 sessions of CBT-IA produced significant reductions in online use time (from an average of 38 hours/week to 16 hours/week), improvement in motivation to engage in offline activities, and symptom reduction maintained at 6-month follow-up. Estimated response rates in clinical trials range from 50–70%, though definitions of "response" vary across studies (typically a ≥50% reduction in severity scores or moving below clinical thresholds on validated instruments).

Motivational Interviewing (MI)

Motivational Interviewing is particularly useful in this population given the high rates of ambivalence and low treatment motivation among individuals with IGD and PSMU, many of whom enter treatment at the behest of family members rather than through intrinsic motivation. MI can be delivered as a standalone brief intervention (typically 1–4 sessions) or as a precursor to CBT.

A randomized controlled trial by Li & Wang (2013) found that a 6-session MI intervention significantly reduced internet addiction severity scores and gaming time compared to a waitlist control, with a large effect size (d = 0.89). However, head-to-head comparisons between MI and CBT are scarce, and the most pragmatic clinical approach appears to be a sequential model: MI to build readiness for change, followed by CBT for skill-building and relapse prevention.

Family-Based and Systemic Interventions

For adolescents with IGD, family-based interventions are critical. Excessive gaming in adolescents frequently occurs in the context of family conflict, parental disengagement, or overly permissive boundaries around technology. Family therapy models that address communication patterns, negotiation of gaming limits, and management of parental anxiety about their child's behavior have shown promising results. A study by Han et al. (2012) found that a combined family therapy and CBT program for adolescents with IGD produced greater reductions in gaming time and depressive symptoms than CBT alone. However, family therapy has not been studied as a standalone treatment in adequately powered RCTs.

Pharmacotherapy

No medication has received FDA approval (or equivalent regulatory approval in other countries) specifically for IGD or PSMU. Pharmacological approaches are extrapolated from the gambling disorder and substance use disorder literatures, and the evidence base consists primarily of small open-label trials and a limited number of RCTs:

• Bupropion: An open-label trial by Han et al. (2010) treated 11 adults with IGD and comorbid MDD with bupropion SR 150 mg twice daily for 6 weeks. Participants showed significant reductions in gaming time (from approximately 35 to 16 hours/week) and depression scores. A subsequent RCT by the same group compared bupropion to no pharmacotherapy in 50 participants with IGD, finding that bupropion significantly reduced craving and total gaming hours. However, sample sizes remain small and replication in larger trials is needed.
• Methylphenidate: In individuals with comorbid ADHD, methylphenidate treatment has been shown to reduce internet gaming time and impulsivity. Han et al. (2009) conducted an 8-week open-label study of methylphenidate in 62 children with ADHD and internet addiction, finding significant reductions in internet use severity scores and ADHD symptoms.
• SSRIs (Escitalopram): A small RCT by Dell'Osso et al. (2008) examined escitalopram for impulsive-compulsive internet use. After 10 weeks of open-label escitalopram (mean dose 20 mg), followed by a 9-week double-blind discontinuation phase, relapse rates were significantly higher in the placebo-switch group, suggesting a genuine treatment effect. However, this was a very small study (n = 19).
• N-Acetylcysteine (NAC): Based on its glutamate-modulating properties and demonstrated efficacy in gambling disorder, NAC has been explored for internet addiction. Preliminary data are encouraging but limited to open-label case series.

Overall, the pharmacotherapy evidence is Level C (limited evidence) for all agents. Estimated NNT cannot be reliably calculated from the available small trials. Pharmacotherapy should generally be considered adjunctive to psychotherapy, particularly for treatment of comorbid conditions (depression, ADHD, anxiety) that perpetuate the behavioral addiction.

Residential and Intensive Outpatient Programs

Specialized residential treatment programs for IGD exist in several countries, most prominently in South Korea, China, Japan, and increasingly in Europe and North America. These programs typically involve complete digital detox for a period of 30–90 days, combined with structured group therapy, physical activity, life skills training, and family involvement. Published outcome data from these programs are limited by selection bias and lack of controlled comparisons, but reported abstinence or controlled-use rates at 6–12 months range from 40–60% in treated samples. South Korea's national "Save the Brain" program and its network of internet addiction counseling centers represent one of the most systematically implemented public health responses globally.

Head-to-Head Comparisons: What We Know and Don't Know

Direct head-to-head comparisons between treatment modalities are rare. The available evidence supports CBT as the first-line treatment with the strongest evidence base, MI as a useful adjunct or standalone brief intervention, pharmacotherapy as primarily adjunctive (particularly for comorbidity), and family-based approaches as important for adolescent cases. There is no high-quality evidence to determine whether combined CBT + pharmacotherapy is superior to CBT alone for IGD specifically, though by analogy with other psychiatric conditions and preliminary data, combined treatment is likely beneficial for individuals with significant comorbid depression or ADHD.

Identifying prognostic factors is essential for clinical decision-making and patient counseling. The following factors have been associated with treatment outcomes in the IGD and PSMU literature:

Favorable Prognostic Indicators

• Higher motivation for change (measured by readiness-to-change scales): Consistently the strongest predictor of treatment engagement and outcome across studies
• Intact social support networks and presence of at least one close offline relationship
• Shorter duration of problematic use (< 2 years before treatment entry)
• Absence of comorbid substance use disorder
• Parental involvement in treatment (for adolescent cases): Associated with 1.5–2x higher response rates compared to individual treatment alone in some studies
• Higher educational attainment and employment

Unfavorable Prognostic Indicators

• Comorbid depression of moderate-to-severe severity, particularly when untreated: Comorbid MDD is associated with approximately 40–50% lower response rates to behavioral interventions for IGD
• Comorbid ADHD (when unaddressed): Impulsivity compromises the capacity to implement behavioral change strategies
• Social isolation — individuals whose entire social network exists online face a dilemma: reducing gaming/social media use means losing their primary (and often only) source of social connection
• Early onset (before age 12): Earlier onset is associated with more severe presentations and longer duration of illness, potentially reflecting a developmental vulnerability
• High trait impulsivity (measured by instruments such as the Barratt Impulsiveness Scale): One of the most robust personality-level predictors of poor outcome
• Continued access to gaming/social media without environmental structure: Unlike substance use disorders, complete abstinence from digital technology is often impractical, making environmental management challenging

Long-term outcome data remain limited. The few longitudinal studies available suggest that IGD follows a chronic-relapsing course in approximately 30–50% of identified cases, with periods of remission and exacerbation often tracking with life stressors. Spontaneous remission does occur, particularly during life transitions (e.g., entering the workforce, forming romantic relationships), though rates are poorly characterized.

One of the most distinctive clinical challenges in treating IGD and PSMU — distinguishing these conditions from substance use disorders and even gambling disorder — is the question of treatment goal: abstinence or moderated use?

For substance use disorders, abstinence has traditionally been the gold-standard treatment goal (though moderation management has gained ground in some contexts, particularly for alcohol use disorder). For IGD and PSMU, complete abstinence from digital technology is often neither feasible nor desirable. Computers and smartphones are essential tools for education, employment, and social participation. Many treatment programs therefore adopt a controlled-use or harm-reduction model, aiming to help individuals establish healthy boundaries and reduce use to non-pathological levels.

However, this approach introduces challenges analogous to treating binge eating disorder (where food abstinence is impossible): the individual must repeatedly engage with the stimulus environment while maintaining controlled behavior. Some clinicians advocate for abstinence from the specific problematic application (e.g., a particular game or social media platform) while maintaining general technology use. Others focus on time-based and context-based rules (e.g., no gaming on weekdays, no social media in the bedroom). The optimal approach likely varies by individual, and comparative effectiveness data for abstinence vs. moderation goals do not exist for IGD.

The built-in engagement-maximizing features of both games and social media platforms represent a further complication with no true parallel in other addictions. Variable-ratio reinforcement schedules (loot boxes, notification algorithms, infinite scrolling), social obligation mechanics (streaks, daily rewards, guild commitments), and algorithm-driven personalization make these products inherently designed to resist disengagement. This places the individual in an asymmetric struggle against sophisticated behavioral engineering, a reality that has prompted calls for regulatory intervention alongside clinical treatment.

Children and Adolescents

IGD and PSMU are predominantly conditions of youth. The developing prefrontal cortex — with its immature executive function, impulse control, and future orientation — creates a neurodevelopmental vulnerability to behavioral addictions. Adolescents show greater ventral striatal reactivity to reward cues and less prefrontal regulatory capacity compared to adults, a maturational mismatch that peaks in mid-adolescence and may explain the elevated IGD prevalence in this age group.

For children and adolescents, the American Academy of Pediatrics (AAP) recommends consistent limits on media time, though it stopped issuing specific hourly recommendations in 2016 in favor of individualized family media plans. Treatment for pediatric IGD almost always requires family involvement, and school-based prevention programs have shown modest efficacy. A South Korean school-based prevention program (the Internet Rescue Camp) reported that a 12-day therapeutic camp involving CBT, physical activity, and digital detox reduced internet addiction severity scores by 30–40%, with effects partially maintained at 3-month follow-up.

The clinician must also navigate the developmentally appropriate role of gaming and social media in peer socialization. For many adolescents, gaming is a primary social activity, and exclusion from gaming can paradoxically increase social isolation. Treatment goals must therefore balance harm reduction with social developmental needs.

Cross-Cultural Considerations

The clinical and research landscape for IGD and PSMU is heavily influenced by East Asian countries — particularly South Korea, China, and Japan — where internet addiction was recognized as a public health crisis earlier than in Western countries. South Korea designated internet addiction as a national health issue in 2011, and China has operated residential "boot camps" for internet-addicted youth since the mid-2000s (though some of these programs have drawn criticism for coercive methods). Cultural factors such as academic pressure, cramped urban living with limited outdoor recreation, high-speed internet infrastructure, and the social centrality of online gaming (e.g., the competitive gaming culture in South Korea) influence both prevalence and presentation.

Western clinicians should be cautious about directly applying prevalence estimates or treatment protocols from East Asian studies to their populations, while also recognizing that the neurobiological underpinnings of these conditions are likely universal even if their expression is culturally shaped.

Despite rapid growth in the literature, the field of IGD and PSMU research faces several significant limitations and active research frontiers:

Nosological Debates

Whether IGD and PSMU are best conceptualized as addictions, impulse control disorders, or symptoms of other conditions (e.g., depression, OCD, ADHD) remains contested. Some researchers (notably Aarseth et al., 2017, in an open debate paper signed by 36 scholars) have argued against the formalization of gaming disorder in the ICD-11, citing concerns about pathologizing normal behavior, premature medicalization, and the low quality of the evidence base. Proponents (e.g., Rumpf et al., 2018) counter that the clinical need is real, the neurobiological parallels with established addictions are strong, and formal recognition is necessary to stimulate high-quality treatment research and ensure access to care.

Measurement Heterogeneity

Over 20 different screening instruments are currently in use for IGD alone, with varying criteria, thresholds, and psychometric properties. This heterogeneity makes cross-study comparison difficult and inflates apparent inconsistencies in prevalence estimates and treatment outcomes. International efforts to harmonize measurement — such as the European COST Action project on internet addiction — are ongoing but have not yet produced a universally accepted gold-standard instrument.

Treatment Research Quality

The treatment literature is dominated by open-label studies, non-randomized designs, small sample sizes, and short follow-up periods. Adequately powered, multisite RCTs with active controls and long-term follow-up (≥12 months) are rare. No Phase III equivalent pharmaceutical trial has been completed for IGD. This limits confidence in treatment effect estimates and prevents reliable calculation of NNT for specific interventions.

Emerging Research Directions

• Neuromodulation: Transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) targeting the dlPFC have shown preliminary promise in reducing craving and gaming behavior in small pilot studies. A sham-controlled trial of rTMS over the left dlPFC by Lee et al. (2018) found significant reductions in craving and gaming duration, but replication in larger samples is needed.
• Digital therapeutics: App-based interventions incorporating CBT principles, real-time usage monitoring, and AI-driven personalized nudges are being developed, though evidence for efficacy is in early stages.
• Biomarker research: Efforts to identify EEG, fMRI, or blood-based biomarkers that can distinguish pathological from high-engagement users, predict treatment response, or guide personalized treatment are active but have not yet yielded clinically usable tools.
• Regulatory and public health approaches: China's 2021 regulation limiting minors' online gaming to 3 hours per week, South Korea's (now-repealed) "Cinderella law" banning gaming for children under 16 between midnight and 6 AM, and the EU Digital Services Act represent policy-level experiments whose long-term impact on population prevalence is being studied.
• Loot boxes and gambling convergence: The incorporation of chance-based microtransactions ("loot boxes") in games has created a regulatory gray zone between gaming and gambling, with emerging evidence linking loot box spending to both gambling disorder and IGD.

Based on the current evidence, the following clinical recommendations represent a pragmatic synthesis for practitioners encountering IGD and PSMU:

• Screen systematically: Incorporate validated screening instruments (e.g., the Internet Gaming Disorder Scale–Short Form or BSMAS) into routine assessments for adolescents and young adults presenting with depression, anxiety, academic decline, or social withdrawal.
• Conduct thorough differential diagnosis: Determine whether excessive use is a primary behavioral addiction or secondary to depression, anxiety, ADHD, ASD, or social isolation. Treat primary conditions first or concurrently.
• Assess suicidality and comorbidity broadly: Given the high rates of comorbid depression and the emerging association with suicidal ideation, systematic risk assessment is essential.
• Use CBT as the first-line psychotherapy: Adapted protocols (CBT-IA or equivalent) have the strongest evidence base. Integrate MI techniques at the outset to address ambivalence, particularly in treatment-resistant or externally referred individuals.
• Involve family: For adolescent patients, family-based interventions addressing technology boundaries, communication, and parental mental health are critical and should be considered standard practice rather than optional adjuncts.
• Consider pharmacotherapy for comorbidity: Bupropion for co-occurring depression, methylphenidate or other stimulants for confirmed ADHD, or SSRIs for comorbid anxiety or OCD. No current evidence supports pharmacotherapy as monotherapy for IGD or PSMU in the absence of comorbidity.
• Negotiate realistic treatment goals: Complete digital abstinence is rarely feasible. Collaboratively develop a harm-reduction plan that targets the specific problematic application or behavior pattern while preserving functional and prosocial technology use.
• Plan for relapse: Relapse rates are high (estimated at 40–60% within 12 months in treated samples), and ongoing booster sessions or stepped-care models are advisable.
• Advocate for environmental change: Clinicians should support patients in environmental restructuring (e.g., removing gaming setups from bedrooms, using app-based time limiters) and, where appropriate, advocate for platform-level regulatory measures that reduce predatory design features.